✦ LIBER ✦

Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study

✍ Scribed by G. Grunberger; A. Chang; G. Garcia Soria; F. T. Botros; R. Bsharat; Z. Milicevic

Book ID: 117949863
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 264 KB
Volume: 29
Category: Article
ISSN: 0742-3071
DOI: 10.1111/j.1464-5491.2012.03745.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monotherapy with the once-weekly GLP-1 a

Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study

✍ G. Grunberger; A. Chang; G. Garcia Soria; F. T. Botros; R. Bsharat; Z. Milicevic 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

Diabet. Med. 29, 1260–1267 (2012) ## Abstract **Aims** Evaluate dose‐dependent effects of once‐weekly dulaglutide, a glucagon‐like peptide‐1 analogue, on glycaemic control in patients with Type 2 diabetes treated with lifestyle measures with or without previous metformin. **Methods** This 12‐week

Dose-dependent effects of the once-daily

Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial

✍ R. E. Ratner; J. Rosenstock; G. Boka; on behalf of the DRI6012 Study Investigato 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Safety and tolerability of high doses of

Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study

✍ R. Ratner; M. Nauck; C. Kapitza; V. Asnaghi; M. Boldrin; R. Balena 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

Effects of transglucosidase on diabetes,

Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial

✍ M. Sasaki; K. Imaeda; N. Okayama; T. Mizuno; H. Kataoka; T. Kamiya; E. Kubota; N 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

Effects of once-daily teneligliptin on 2

Effects of once-daily teneligliptin on 24-h blood glucose control and safety in Japanese patients with type 2 diabetes mellitus: a 4-week, randomized, double-blind, placebo-controlled trial

✍ T. Eto; S. Inoue; T. Kadowaki 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)

✍ Y. Seino; K. W. Min; E. Niemoeller; A. Takami; on behalf of the EFC10887 GETGOAL 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB